What You Should Know
Value-based obesity management leader Ilant Health has closed a $15M Series A funding round led by Cornucopian Capital, elevating its total funding footprint past $22 million.The financing round features strategic participation from naturalX, Peakbridge, Semcap AI, Evidenced, Operator Partners, and existing investors Celtic, LifeX, and AlphaLab.Founded by former McKinsey and Molina Healthcare executive Elina Onitskansky, the company bypasses fragmented weight-loss apps to
Read More
GLP-1
Noom Launches $125 At-Home Biomarker Test Kit to Track HbA1c and Cardiovascular Risks for GLP-1 Users
What You Should Know
Digital health and behavior change leader Noom has launched a $125 at-home Biomarkers Test Kit for its U.S. membership base, targeting comprehensive metabolic and cardiovascular tracking.Utilizing the Tasso+ device for painless blood collection, the kit tracks 17 clinically significant biomarkers, including gold-standard measures like HbA1c, ApoB, triglycerides, hs-CRP, and the genetic risk factor Lp(a).Early data from Noom’s Proactive Health program reveals severe hidden
Read More
Twin Health Launches AI-Native GLP-1 Stewardship Model to Slash Cardiometabolic Spending for Employers
What You Should Know
Digital Twin Care Platform pioneer Twin Health has officially launched its proprietary GLP-1 Stewardship Model, establishing a clear clinical framework to reduce long-term patient dependence on high-cost weight loss medications.In a randomized clinical trial published in the New England Journal of Medicine Catalyst, 85% of Twin participants successfully discontinued GLP-1 therapies while losing two times more weight than the control group.The model introduces strict
Read More
Amazon One Medical Launches Nationwide GLP-1 Management Program Integrated with Primary Care
What You Should Know
The Launch: Amazon One Medical has rolled out a nationwide GLP-1 management program that explicitly integrates obesity treatment with comprehensive primary care.The Clinical Differentiator: Unlike direct-to-consumer "pill mills" that simply dispense weight loss drugs, Amazon is treating obesity as a chronic condition. Because GLP-1s can rapidly alter blood pressure and A1C levels, One Medical clinicians proactively adjust a patient's existing hypertension or diabetes
Read More
Walmart Expands Better Care Services Platform with GLP-1 Weight Management Offerings
What You Should Know
The Expansion: Walmart is heavily expanding its digital health platform, Better Care Services, to include comprehensive weight management support for customers exploring or currently taking GLP-1 therapies.The Digital Health Bundle: The retail giant is acting as a centralized hub, partnering with third-party digital health companies including Aaptiv (fitness), Berry Street (registered dietitians), Curai Health (AI-supported coaching), MyCare by Twin Health (metabolic
Read More
Wegovy HD Now Available on GoodRx for $399 Per Month Self-Pay
What You Should Know
The Launch: GoodRx has announced it is now offering Wegovy HD—Novo Nordisk’s newly introduced, higher-dose (7.2 mg) semaglutide injection.The Price Point: In a major move for the direct-to-consumer market, the medication is available to eligible self-pay patients at a transparent price of $399 per month. Pricing scales predictably to $798 for a two-month supply and $1,197 for a three-month supply.The Clinical Strategy: Wegovy HD serves as an FDA-approved "step-up" option
Read More
eMed Secures $200M Series A at $2B+ Valuation to Scale AI-Powered GLP-1 Employer Platform
What You Should Know
The Mega-Round: Miami-based eMed has raised a $200M Series A funding round, catapulting the company to a valuation of over $2 billion. The round was led by AON Consulting, Inc.The Power Roster: The executive and investor lineup is uniquely high-profile. Former X CEO Linda Yaccarino is now at the helm as eMed's CEO. NFL legend Tom Brady serves as both an investor and the Founding Chief Wellness Officer. The cap table also includes tech and finance heavyweights like Joe
Read More
Weight Watchers Releases GLP-1 Results Report Demonstrating 61% Greater Weight Loss
What You Should Know:
The Strategic Pivot Validated: Weight Watchers (WW) has released GLP-1 Results Report validating its integrated weight health platform, which combines medical therapy with behavioral support.The Core Data: Members who actively paired weight loss medication with the WW GLP-1 Success Program achieved 61.3% greater average weight loss in their first month compared to those who did not engage in behavioral support.Long-Term Efficacy: WW Med+ members prescribed GLP-1s reached
Read More
Walgreens Launches $49 Pay-Per-Visit Weight Management, Expanding Virtual Healthcare Platform
What You Should Know
The Launch: Walgreens has officially launched Walgreens Weight Management, expanding its Virtual Healthcare platform to offer personalized, clinician-guided weight loss support for eligible adults ages 18-64.The Clinical Pathway: Eligible patients complete an online video visit with a licensed doctor or nurse practitioner who evaluates their medical history and goals. Providers can then prescribe FDA-approved GLP-1 medications (like Wegovy) for weight loss.The Pricing
Read More
GLP-1: Amazon Pharmacy Adds Zepbound KwikPen to Its Same-Day Delivery for $299
What You Should Know
The Launch: Amazon Pharmacy has officially expanded its weight management portfolio by adding Eli Lilly's Zepbound® KwikPen® to its digital shelves.The Hardware: Unlike traditional single-use GLP-1 auto-injectors, the KwikPen is a multi-dose device designed to deliver a full month of medication in a single pen, reducing medical waste and simplifying the patient experience.The Disruption: Bypassing the murky world of Pharmacy Benefit Managers (PBMs), Amazon is offering
Read More
